Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015533
Filing Date
2024-11-13
Accepted
2024-11-13 16:20:01
Documents
111
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vreof-20240930x10q.htm   iXBRL 10-Q 1869106
2 EX-10.78 vreof-20240930xex10d78.htm EX-10.78 139170
3 EX-31.1 vreof-20240930xex31d1.htm EX-31.1 17268
4 EX-31.2 vreof-20240930xex31d2.htm EX-31.2 16760
5 EX-32.1 vreof-20240930xex32d1.htm EX-32.1 12446
  Complete submission text file 0001558370-24-015533.txt   9564819

Data Files

Seq Description Document Type Size
6 EX-101.SCH vreof-20240930.xsd EX-101.SCH 83936
7 EX-101.CAL vreof-20240930_cal.xml EX-101.CAL 84652
8 EX-101.DEF vreof-20240930_def.xml EX-101.DEF 300859
9 EX-101.LAB vreof-20240930_lab.xml EX-101.LAB 641641
10 EX-101.PRE vreof-20240930_pre.xml EX-101.PRE 517827
114 EXTRACTED XBRL INSTANCE DOCUMENT vreof-20240930x10q_htm.xml XML 1609666
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56225 | Film No.: 241454593
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)